Skip to main content

Ongoing FDAEvent 99774 (6 days ago)

Cadwell IOMAX Cortical Module

The IOMAX Cortical Module may unintentionally deliver electrical stimulation or allow unintended current to reach the patient.

Moderate risk

Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.

FDA Class II recall · How risk is rated

What to do

What happened

Cadwell Industries Inc is recalling the IOMAX Cortical Module because a defective printed circuit board assembly may cause the device to unintentionally deliver electrical stimulation to the patient or allow an unintended electrical current to reach the patient. The recall began on August 18, 2026, and was added to the FDA's Enforcement Report on October 9, 2026.

Summary by Recall Canary from the FDA notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the list below, then check the codes the FDA notice also names.

  1. IOMAX Cortical Module

    Model
    • 190296-200

From the FDA notice

UDI-DI code: 00840067100653

Details

Company began the recall
Event ID
99774
Company
Cadwell Industries Inc
  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 10, 2026 · primary source: U.S. Food and Drug Administration